6/18
07:42 am
phio
Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging [Yahoo! Finance]
Low
Report
Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging [Yahoo! Finance]
5/28
07:42 am
phio
Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762 [Yahoo! Finance]
Low
Report
Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762 [Yahoo! Finance]
5/17
09:05 am
phio
Phio Pharmaceuticals Secures New Investor [Yahoo! Finance]
Medium
Report
Phio Pharmaceuticals Secures New Investor [Yahoo! Finance]
5/17
09:00 am
phio
Phio Pharmaceuticals Secures New Investor
Low
Report
Phio Pharmaceuticals Secures New Investor
5/16
08:14 am
phio
Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID) [Yahoo! Finance]
Medium
Report
Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID) [Yahoo! Finance]
5/16
08:00 am
phio
Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)
Medium
Report
Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)
5/15
01:07 pm
phio
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study [Yahoo! Finance]
Low
Report
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study [Yahoo! Finance]
5/15
01:00 pm
phio
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study
Low
Report
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study
5/14
08:07 am
phio
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Medium
Report
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
5/9
05:31 pm
phio
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update [Yahoo! Finance]
5/9
05:25 pm
phio
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
Medium
Report
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
4/30
07:42 am
phio
Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO) [Yahoo! Finance]
Low
Report
Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO) [Yahoo! Finance]
4/30
07:30 am
phio
Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)
Low
Report
Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)
4/22
01:10 pm
phio
Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
High
Report
Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
4/16
07:45 am
phio
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID) [Yahoo! Finance]
Medium
Report
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID) [Yahoo! Finance]
4/16
07:30 am
phio
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
Low
Report
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
4/11
07:30 am
phio
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
Low
Report
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
4/3
07:30 am
phio
National Spotlight Features Phio’s Innovative RNAi Technology Platform
Low
Report
National Spotlight Features Phio’s Innovative RNAi Technology Platform
4/2
07:39 am
phio
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update [Yahoo! Finance]
4/2
07:30 am
phio
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
Medium
Report
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
3/21
07:37 am
phio
Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies [Yahoo! Finance]
High
Report
Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies [Yahoo! Finance]
3/21
07:30 am
phio
Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
High
Report
Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies